Revumenib as maintenance for AML following allogeneic stem cell transplantation.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hannah Goulart, Olayinka Okeleji, Courtney Denton DiNardo, Naval Guastad Daver, Tapan M. Kadia, Alex Bataller, Hagop M. Kantarjian, Hussein Abbas, Wei Ying Jen, Jeremy Connors, David McCall, Guillermo Garcia-Manero, Nicholas James Short, Uday R. Popat, Demetrios Petropoulos, Priti Tewari, Gheath Alatrash, Elizabeth J. Shpall, Branko Cuglievan, Ghayas C. Issa
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Syndax Pharmaceuticals
OpenAlex ID: W7162525467
Cites:
Cited by:
Related to: